Article
APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease
6 Mar 2023
Abstract excerpt
Alzheimer's disease (AD) is a progressive neurodegenerative disease, the main pathological hallmark of which is the loss of neurons, resulting in cognitive and memory impairments. Sporadic late-onset AD is a prevalent form of the disease and the apolipoprotein E4 (APOE4) genotype is the strongest predictor of the disease development. The structural variations of APOE isoforms affect their roles in synaptic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
